共 26 条
[1]
PATERSON I.C., CROMPTON G.K., Use of pressurised aerosols by asthmatic patients, Br Med J., 1, pp. 76-77, (1976)
[2]
OREHEK J., GAYRARD P., GRIMAUD C., CHARPIN J., Patient error in use of bronchoddlator metered aerosols, Br Med J., 1, (1976)
[3]
CROMPTON G.K., Problems patients have using pressurised aerosols, Eur J Respir Dis., 63, pp. 101-104, (1982)
[4]
EPSTEIN S.W., MANNING G.P.R., ASHLEY M.J., COREY P.M., Survey of clinical use of pressurised aerosol inhalers, Can Med Assoc J., 120, pp. 813-816, (1976)
[5]
NEWMAN S.P., Metered dose pressurised aerosols and the ozone layer, Eur Respir J., 3, pp. 495-497, (1990)
[6]
DUNCAN D., PATERSON I.C., HARRIS D., CROMPTON G.K., Comparison of the bronchodilator effects of salbutamol inhaled as a dry powder and by conventional aerosol, Br J Clin Pharmacol., 4, pp. 669-671, (1977)
[7]
CROMPTON G.K., DUNCAN J., Clinical assessment of a new breath-actuated inhaler, Practitioner., 233, pp. 268-269, (1989)
[8]
CROMPTON G.K., The role of inhaled beta-agonists and different delivery systems in asthma, In: A new concept in inhalation therapy, pp. 71-75, (1987)
[9]
DUNCAN J., NING A.C.W.S., CROMPTON G.K., Clinical assessment of a new multidose nonpressurised metered-dose inhaler, Drug Invest, 2, pp. 136-137, (1990)
[10]
Glaxo